Skip to main content

Abhängiges Verhalten bei Suchterkrankungen

Neurobiologie

  • Chapter
Handbuch der psychiatrischen Pharmakotherapie

Zusammenfassung

Die Betrachtung der Ursachen abhängigen Verhaltens bei Personen mit einer Substanzabhängigkeit aus neurobiologischer Perspektive ist komplex. So sind allen stoffgebundenen Abhängigkeitserkrankungen einige klinische Merkmale gemeinsam.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ait-Daoud N, Johnson BA, Prihoda TJ, Hargita ID (2001) Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence. Psychopharmacology (Berl) 154: 23–27

    CAS  Google Scholar 

  • Akash KG, Balarama KS, Paulose CS (2008) Enhanced 5-HT(2A) receptor status in the hypothalamus and corpus striatum of ethanol-treated rats. Cell Mol Neurobiol 28: 1017–1025

    CAS  PubMed  Google Scholar 

  • Bechara A (2004) Disturbances of emotion regulation after focal brain lesions. Int Rev Neurobiol 62: 159–193

    PubMed  Google Scholar 

  • Beck A, Schlagenhauf F, Wustenberg T et al (2009) Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics. Biol Psychiatry 66: 734–742

    CAS  PubMed  Google Scholar 

  • Belujon P, Grace AA (2011) Hippocampus, amygdala, and stress: interacting systems that affect susceptibility to addiction. Ann NY Acad Sci 1216: 114–121

    PubMed Central  CAS  PubMed  Google Scholar 

  • Benkert O, Hippius H (2011) Kompendium der Psychiatrischen Pharmakotherapie, 8. Aufl. Springer, Berlin, Heidelberg, New York

    Google Scholar 

  • Berger SL (2007) The complex language of chromatin regulation during transcription. Nature 447: 407–412

    CAS  PubMed  Google Scholar 

  • Berger SP, Hall S, Mickalian JD et al (1996) Haloperidol antagonism of cueelicited cocaine craving. Lancet 347: 504–508

    CAS  PubMed  Google Scholar 

  • Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31–39

    CAS  PubMed  Google Scholar 

  • Blum K, Chen AL, Chen TJ et al (2008) Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. Theor Biol Med Model 12(5): 24

    Google Scholar 

  • Boning J (1992) Zur Neurobiologie und Phanomenologie eines »Suchtgedachtnisses«. Sucht 38: 105–106

    Google Scholar 

  • Bowers MS, Chen BT, Chou JK et al (2007) Acamprosate attenuates cocaineand cue-induced reinstatement of cocaine-seeking behavior in rats. Psychopharmacology (Berl) 195: 397–406

    CAS  Google Scholar 

  • Budde H, Sander T, Wernicke C et al (2010) Serotonin transporter promoter polymorphism and dopaminergic sensitivity in alcoholics. J Neural Transm 117: 133–138

    CAS  PubMed  Google Scholar 

  • Carboni E, Acquas E, Frau R, Di Chiara G (1989) Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release. Eur J Pharmacol 164: 515–519

    CAS  PubMed  Google Scholar 

  • Chua EF, Schacter DL, Sperling RA (2009) Neural correlates of metamemory: a comparison of feeling-of-knowing and retrospective confidence judgements. J Cogn Neurosci 21: 1751–1765

    PubMed Central  PubMed  Google Scholar 

  • Craig AD (2009) How do you feel now? The anterior insula and human awareness; Nat Rev Neurosci 10: 59–70

    CAS  Google Scholar 

  • Croissant B, Klein O, Gehrlein L et al (2006) Quetiapine in relapse prevention in alcoholics suffering from craving and affective symptoms: a case series. Eur Psychiatry 21: 570–573

    CAS  PubMed  Google Scholar 

  • Cowen MS, Lawrence AJ (1999) The role of opioid-dopamine interactions in the induction and maintenance of ethanol consumption. Prog Neuropsychopharmacol Biol Psychiatry 23: 1171–1212

    CAS  PubMed  Google Scholar 

  • Daglish MR, Williams TM, Wilson SJ et al (2008) Brain dopamine response in human opioid addiction. Br J Psychiatry 193: 65–72

    PubMed  Google Scholar 

  • Diana M, Muntoni AL, Pistis M et al (1999) Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. Eur J Neurosci 11: 1037–1041

    CAS  PubMed  Google Scholar 

  • Dick DM, Foroud T (2003) Candidate genes for alcohol dependence: a review of genetic evidence from human studies. Alcohol Clin Exp Res 27: 868–879

    PubMed  Google Scholar 

  • Dick DM, Rose RJ, Viken RJ et al (2001) Exploring gene-environment interactions: socioregional moderation of alcohol use. J Abnorm Psychol 110: 625–632

    CAS  PubMed  Google Scholar 

  • Edwards G (1990) Withdrawal symptoms and alcohol dependence: fruitful mysteries. Br J Addict 85: 447–461

    CAS  PubMed  Google Scholar 

  • Feltenstein MW, Do PH, See RE (2009) Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse. Psychopharmacology (Berl) 207: 401–411

    CAS  Google Scholar 

  • Fils-Aime ML, Eckardt MJ, George DT et al (1996) Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than lateonset alcoholics. Arch Gen Psychiatry 53: 211–216

    CAS  PubMed  Google Scholar 

  • Fiorillo CD, Newsome WT, Schultz W (2008) The temporal precision of reward prediction in dopamine neurons. Nat Neurosci 11: 966–973

    CAS  Google Scholar 

  • Flagel SB, Clark JJ, Robinson TE et al (2011) A selective role for dopamine in stimulus-reward learning. Nature 469: 53–57

    PubMed Central  CAS  PubMed  Google Scholar 

  • Gao C, Che LW, Chen J et al (2003) Ohmefentanyl stereoisomers induce changes of CREB phosphorylation in hippocampus of mice in conditioned place preference paradigm. Cell Res 13: 29–34

    CAS  PubMed  Google Scholar 

  • Garavan H, Stout JC (2005) Neurocognitive insights into substance abuse. Trends Cogn Sci 9: 195–201

    PubMed  Google Scholar 

  • George DT, Rawlings R, Eckardt MJ et al (1998) Buspirone treatment of alcoholism: age of onset, and cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid concentrations, but not medication treatment, predict return to drinking. Alcohol Clin Exp Res 23: 272–278

    Google Scholar 

  • Gianoulakis C (2004) Endogenous opioids and addiction to alcohol and other drugs of abuse. Curr Top Med Chem 4: 39–50

    CAS  PubMed  Google Scholar 

  • Goldstein RZ, Alia-Klein N, Tomasi D et al (2009a) Anterior cingulate cortex hypoactivations to an emotionally salient task in cocaine addiction. Proc Natl Acad Sci USA 106: 9453–9458

    PubMed Central  CAS  PubMed  Google Scholar 

  • Goldstein RZ, Craig AD, Bechara A et al (2009b) The neurocircuitry of impaired insight in drug addiction. Trends Cogn Sci 13: 372–380

    PubMed Central  PubMed  Google Scholar 

  • Grusser SM, Wrase J, Klein S et al (2004) Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology (Berl) 175: 296–302

    Google Scholar 

  • Hebb DO (1949) The organization of behaviour. Wiley, New York

    Google Scholar 

  • Heinz A (2000) Das dopaminerge Verstarkungssystem: Funktion, Interaktion mit anderen Neurotransmittersystemen und psychopathologische Korrelate. Steinkopff, Darmstadt

    Google Scholar 

  • Heinz A., Batra A (2003) Neurobiologie der Alkohol und Nikotinabhangigkeit. In: Brandt, Cohen, Helmchen, Schmidt (Hrsg) Psychiatrie, Neurologie, Klinische Psychologie. Kohlhammer, Stuttgart

    Google Scholar 

  • Heinz A, Lichtenberg-Kraag B, Sällström Baum S et al (1995) Evidence for prolonged recovery of dopaminergic transmission in alcoholics with poor treatment outcome. J Neural Transm 102: 149–158

    CAS  Google Scholar 

  • Heinz A, Dufeu P, Kuhn S et al (1996) Psychopathological and behavioral correlates of dopaminergic sensitivity in alcohol-dependent patients. Arch Gen Psychiatry 53: 1123–1128

    CAS  PubMed  Google Scholar 

  • Heinz A, Siessmeier T, Wrase J et al (2004) Correlation between dopamine D2 receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry 161: 1783–1789

    PubMed  Google Scholar 

  • Heinz A, Beck A, Grusser SM, Grace AA, Wrase J (2009a) Identifying the neural circuitry of alcohol craving and relapse vulnerability. Addict Biol 14: 108–18

    PubMed Central  CAS  PubMed  Google Scholar 

  • Heinz A, Beck A, Wrase J et al (2009b) Neurotransmitter systems in alcohol dependence. Pharmacopsychiatry 42(Suppl 1): S95-S101

    CAS  PubMed  Google Scholar 

  • Hester R, Nestor L, Garavan H (2009) Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology 34: 2450–2458

    PubMed Central  PubMed  Google Scholar 

  • Hommer DW, Bjork JM, Gilman JM (2011) Imaging brain response to reward in addictive disorders. Ann NY Acad Sci 1216: 50–61

    CAS  PubMed  Google Scholar 

  • Ivanov A, Aston-Jones G (2001) Local opiate withdrawal in locus coeruleus neurons in vitro. J Neurophysiol 85: 2388–2397

    CAS  PubMed  Google Scholar 

  • Jackson ME, Moghaddam B (2001) Amygdala regulation of nucleus accumbens dopamine output is governed by the prefrontal cortex. J Neurosci 21: 676–681

    CAS  PubMed  Google Scholar 

  • Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl): 245–254

    CAS  PubMed  Google Scholar 

  • Kiefer F, Mann K (2010) Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy. Curr Pharm Des 16: 2098–2102

    CAS  PubMed  Google Scholar 

  • Kiefer F, Jahn H, Tarnaske T et al (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a doubleblind, placebo-controlled study. Arch Gen Psychiatry 60: 92–99

    CAS  PubMed  Google Scholar 

  • Kienast T, Wrase J, Heinz A (2008) Neurobiology of substance-related addiction: findings of neuroimaging. Fortschr Neurol Psychiatr 76(Suppl 1): S68–76

    PubMed  Google Scholar 

  • Kim M, Au E, Neve R, Yoon BJ (2009) AMPA receptor trafficking in the dorsal striatum is critical for behavioral sensitization to cocaine in juvenile mice. Biochem Biophys Res Commun 379(1): 65–69

    CAS  PubMed  Google Scholar 

  • Konorski J (1948) Conditioned reflexes and neuron organisation. Cambridge University Press, Cambridge

    Google Scholar 

  • Koob G F, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278: 52–58

    CAS  PubMed  Google Scholar 

  • Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35: 217–238

    PubMed Central  PubMed  Google Scholar 

  • Kranzler HR, Pierucci-Lagha A, Feinn R, Hernandez-Avila C (2003) Effects of ondansetron in early- versus late-onset alcoholics: a prospective, openlabel study. Alcohol Clin Exp Res 27: 1150–1155

    CAS  PubMed  Google Scholar 

  • Kullmann DM, Lamsa KP (2011) LTP and LTD in cortical GABAergic interneurons: emerging rules and roles. Neuropharmacology 60(5): 712–719

    CAS  PubMed  Google Scholar 

  • Kumar S, Porcu P, Werner DF et al (2009) The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress. Psychopharmacology (Berl) 205: 529–564

    CAS  Google Scholar 

  • Land BB, Bruchas MR, Schattauer S et al (2009) Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc Natl Acad Sci USA 106: 19168–19173

    PubMed Central  CAS  PubMed  Google Scholar 

  • Lee BR, Dong Y (2011) Cocaine-induced metaplasticity in the nucleus accumbens: Silent synapse and beyond. Neuropharmacology 61(7): 1060–1069

    PubMed Central  CAS  PubMed  Google Scholar 

  • Lee AM, Messing RO (2008) Protein kinases and addiction. Ann NY Acad Sci 1141: 22–57

    PubMed Central  CAS  PubMed  Google Scholar 

  • Lin Z, Uhl GR (2002) Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism. Mol Pharmacol 61: 885–891

    CAS  PubMed  Google Scholar 

  • Lisman J, Morris RG (2001) Memory. Why is the cortex a slow learner? Nature 411: 248–249

    CAS  PubMed  Google Scholar 

  • Maldonado R, Salardi A, Valverde O et al (1997) Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388: 586–589

    CAS  PubMed  Google Scholar 

  • Mayer EA, Naliboff B, Munakata J (2000) The evolving neurobiology of gut feelings. Prog Brain Res 122: 195–206

    CAS  PubMed  Google Scholar 

  • Maze I, Nestler EJ (2011) The epigenetic landscape of addiction. Ann NY Acad Sci 1216: 99–113

    PubMed Central  CAS  PubMed  Google Scholar 

  • Mihic SJ, Ye Q, Wick MJ et al (1997) Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 389: 385–389

    CAS  PubMed  Google Scholar 

  • Moron JA, Gullapalli S, Taylor C et al (2010) Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation. Neuropsychopharmacology 35: 955–966

    PubMed Central  CAS  PubMed  Google Scholar 

  • Moussawi K, Pacchioni A, Moran M et al (2009) N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat Neurosci 12: 182–189

    PubMed Central  CAS  PubMed  Google Scholar 

  • Moussawi K, Zhou W, Shen H et al (2010) Reversing cocaine-induced synaptic potentiation provides enduring protection from relapse. Proc Natl Acad Sci USA 108: 385–390

    PubMed Central  PubMed  Google Scholar 

  • Muller DJ, Likhodi O, Heinz A (2010) Neural markers of genetic vulnerability to drug addiction. Curr Top Behav Neurosci 3: 277–299

    PubMed  Google Scholar 

  • Nader MA, Morgan D, Gage HD et al (2006) PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci 9: 1050–1956

    CAS  PubMed  Google Scholar 

  • Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2: 119–128

    CAS  PubMed  Google Scholar 

  • Nestler EJ, Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278: 58–63

    CAS  PubMed  Google Scholar 

  • Noble F, Cox BM (1996) Differential desensitization of μ- and δ-opioid receptors in selected neural pathways following chronic morphine treatment. Br J Pharmacol 117: 161–169

    PubMed Central  CAS  PubMed  Google Scholar 

  • O’Brien CP, Terenius LY, Nyberg N et al (1988) Endogenous opioids in the cerebrospinal fluid of opiate-dependent humans. Biol Psychiatr 24: 649–662

    Google Scholar 

  • Paulus MP, Tapert SF, Schuckit MA (2005) Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Arch Gen Psychiatry 62: 761–768

    PubMed  Google Scholar 

  • Perez MF, Ford KA, Goussakov I et al (2011) Repeated cocaine exposure decreases dopamine D2-like receptor modulation of Ca(2+) homeostasis in rat nucleus accumbens neurons. Synapse 65: 168–180

    PubMed Central  CAS  PubMed  Google Scholar 

  • Perreau-Lenz S, Sanchis-Segura C, Leonardi-Essmann F et al (2010) Development of morphine-induced tolerance and withdrawal: involvement of the clock gene mPer2. Eur Neuropsychopharmacol 20: 509–517

    CAS  PubMed  Google Scholar 

  • Ridderinkhof KR, Ullsperger M, Crone EA, Nieuwenhuis S (2004) The role of the medial frontal cortex in cognitive control. Science 306: 443–447

    CAS  PubMed  Google Scholar 

  • Rocha BA, Fumagalli F, Gainetdinov RR et al (1998) Cocaine self-administration in dopamine-transporter knockout mice. Nature Neurosci 1: 132–137

    CAS  PubMed  Google Scholar 

  • Rosner S, Hackl-Herrwerth A, Leucht S et al (2010a) Acamprosate for alcohol dependence. Cochrane Database Syst Rev 9: CD004332

    PubMed  Google Scholar 

  • Rosner S, Hackl-Herrwerth A, Leucht S et al (2010b) Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 12: CD001867

    PubMed  Google Scholar 

  • Saal D, Dong Y, Bonci A, Malenka RC (2003) Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37: 577–582

    CAS  PubMed  Google Scholar 

  • Seeley WW, Allman JM, Carlin DA et al (2007) Divergent social functioning in behavioral variant frontotemporal dementia and Alzheimer disease: reciprocal networks and neuronal evolution. Alzheimer Dis Assoc Disord 21: S50–57

    PubMed  Google Scholar 

  • Self D (2003) Neurobiology: dopamine as chicken and egg. Nature 422: 573–574

    CAS  PubMed  Google Scholar 

  • Shaham Y, Hope BT (2005) The role of neuroadaptations in relapse to drug seeking. Nat Neurosci 8: 1437–1439

    CAS  PubMed  Google Scholar 

  • Siegel S (1983) Classical conditioning, drug tolerance and drug dependence. In: Israel I, Glaser FB, Kalant H et al (eds) Research advances in alcohol and drug problems. Plenum Press, New York, pp 207–246

    Google Scholar 

  • Spanagel R, Sillaber I, Zieglgänsberger W et al (1998) Acamprosate suppresses the expression of morphine-induced sensitization in rats but does not affect heroin self-administration or relapse induced by heroin or stress. Psychopharmacology 139: 391–401

    CAS  PubMed  Google Scholar 

  • Tiihonen J, Vilkman H, Rasanen P et al (1998) Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography. Mol Psychiatry 3: 156–161

    CAS  PubMed  Google Scholar 

  • Umhau JC, Momenan R, Schwandt ML et al (2010) Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study. Arch Gen Psychiatry 67: 1069–1077

    PubMed Central  CAS  PubMed  Google Scholar 

  • Vanderschuren LJ, Pierce RC (2010) Sensitization processes in drug addiction. Curr Top Behav Neurosci 3: 179–195

    PubMed  Google Scholar 

  • Vengeliene V, Bilbao A, Molander A, Spanagel R (2008) Neuropharmacology of alcohol addiction. Br J Pharmacol 154: 299–315

    PubMed Central  CAS  PubMed  Google Scholar 

  • Verheul R, Van Den Brink W, Geerlings P (1999) A three-pathway psychobiological model of craving for alcohol. Alcohol Alcohol 34: 197–222

    CAS  PubMed  Google Scholar 

  • Vigano D, Rubino T, Di Chiara G et al (2003) Mu opioid receptor signaling in morphine sensitization. Neuroscience 117: 921–929

    CAS  PubMed  Google Scholar 

  • Volkow ND, Wang GJ, Fowler JS et al (1997) Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386: 830–833

    CAS  PubMed  Google Scholar 

  • Volpicelli JR, Alterman AI, Hayashida M, O’Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49: 876–880

    CAS  PubMed  Google Scholar 

  • Volpicelli JR, Watson NT, King AC et al (1995) Effect of naltrexone on alcohol »high« in alcoholics. Am J Psychiatry 152: 613–615

    CAS  PubMed  Google Scholar 

  • Vorel SR, Liu X, Hayes RJ, Spector JA, Gardner EL (2001) Relapse to cocaineseeking after hippocampal theta burst stimulation. Science 292: 1175–1178

    CAS  PubMed  Google Scholar 

  • Walters CL, Kuo YC, Blendy JA (2003) Differential distribution of CREB in the mesolimbic dopamine reward pathway. J Neurochem 87: 1237–1244

    CAS  PubMed  Google Scholar 

  • Wang GJ, Volkow ND, Fowler JS et al (1997) Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology 16: 174–182

    CAS  PubMed  Google Scholar 

  • Wiesbeck GA, Weijers HG, Lesch OM et al (2001) Flupentixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled study. Alc Alcoholism 36: 329–334

    CAS  Google Scholar 

  • Wikler A (1948) Recent progress in research on the neurophysiological basis of morphin addiction. Am J Psychiatry 105: 329–338

    CAS  PubMed  Google Scholar 

  • Willuhn I, Wanat MJ, Clark JJ, Phillips PE (2010) Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse. Curr Top Behav Neurosci 3: 29–71

    PubMed Central  PubMed  Google Scholar 

  • Wise RA (1982) Neuroleptics and operant behavior: the anhedonia hypothesis. Behav Brain Sci 5: 39–87

    Google Scholar 

  • Wise RA (2008) Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res 14: 169–183

    PubMed Central  PubMed  Google Scholar 

  • Wolffe AP, Matzke MA (1999) Epigenetics: regulation through repression. Science 286: 481–486

    CAS  PubMed  Google Scholar 

  • Xiao C, Zhang J, Krnjević K, Ye JH (2007) Effects of ethanol on midbrain neurons: role of opioid receptors. Alcohol Clin Exp Res 31: 1106–1113

    CAS  PubMed  Google Scholar 

  • Yi Wong CC, Mill J, Fernandes C (2011) Drugs and addiction: an introduction to epigenetics. Addiction 106(3): 480–489

    PubMed  Google Scholar 

  • Zaniewska M, McCreary AC, Wydra K, Filip M (2010) Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment. Synapse 64: 511–519

    CAS  PubMed  Google Scholar 

  • Zhang J, Xu M (2006) Opposite regulation of cocaine-induced intracellular signaling and gene expression by dopamine D1 and D3 receptors. Ann NY Acad Sci 1074: 1–12

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kienast, T., Heinz, A. (2012). Abhängiges Verhalten bei Suchterkrankungen. In: Gründer, G., Benkert, O. (eds) Handbuch der psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19844-1_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-19844-1_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-19843-4

  • Online ISBN: 978-3-642-19844-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics